The research, published in Frontiers in Aging, drew on the Singapore Chinese Health Study, a population-based cohort of 63,257 Chinese men and women recruited between 1993 and 1998. Because smoking was rare among the cohort’s women — only three percent smoked at baseline — the analysis focused on men. From the original male participants, 4,574 individuals met the study’s criteria: they had complete smoking data across four study visits spanning roughly twenty years, were between 45 and 65 years old at enrollment, and completed a frailty assessment in late life, at a mean age of 73.6 years.

What distinguishes this study from much of the existing literature is its meticulous, repeated ascertainment of smoking behavior. Participants were asked at baseline and at three follow-up interviews, conducted five to six years apart, whether they had ever smoked at least one cigarette a day for a year or longer. Those who reported never smoking across all four visits were classified as never smokers; those who reported current smoking at every visit were persistent smokers; and those who reported a history of smoking without ever resuming were former smokers. Crucially, anyone who relapsed after an initial quit attempt was excluded, a step designed to avoid misclassification that could distort risk estimates.

Frailty was assessed at the third follow-up using a modified version of the well-known Cardiovascular Health Study frailty phenotype, originally defined by Fried and colleagues around five criteria: unintentional weight loss, weakness, exhaustion, slow walking speed, and low physical activity. Because physical activity data were not collected in this format, the Singapore team used four criteria — weight loss of at least ten percent of body weight between the second and third follow-ups, exhaustion based on a self-reported energy question, slowness measured by the slowest sex-specific quintile on the Timed Up-and-Go test, and weakness defined by the weakest sex-specific quintile of handgrip strength. Meeting at least two of the four criteria classified a participant as frail. In total, 629 men, or 13.8 percent of the analytic sample, met that threshold.

The headline result concerns persistent smokers. After an average follow-up of 20.9 years, men who smoked at every assessment had 34 percent higher odds of late-life frailty than never smokers, with a fully adjusted odds ratio of 1.34 and a confidence interval of 1.01 to 1.76 — statistically significant even after extensive adjustment for age, dialect group, education, body mass index, alcohol consumption, sleep duration, diet quality measured by DASH score, caffeine intake, physical activity, and baseline and late-life medical history of hypertension, diabetes, and cardiovascular disease. The finding confirms, in one of the longest prospective windows available, that sustained smoking is a modifiable risk factor for the physical decline that shadows aging.

The more nuanced story lies among the quitters. Men who had stopped smoking fewer than ten years before the frailty assessment showed an odds ratio of 1.33 — numerically almost identical to that of persistent smokers — though the confidence interval of 0.86 to 2.01 was wide and not statistically significant, likely reflecting the smaller number of recent quitters. But once the quit duration crossed the ten-year threshold, the excess risk effectively dissolved. Those who quit ten to twenty years earlier had an odds ratio of 1.08, those who quit twenty to thirty years earlier had 0.91, those quitting thirty to forty years earlier had 0.85, and those abstinent for more than forty years had an odds ratio of 0.97 — indistinguishable from never smokers in every case. The formal test for a stepwise trend across cessation durations did not reach significance, but the pattern is clear: a decade of abstinence appears to be the dividing line.

Age at quitting told a strikingly parallel story. Men who quit before their sixtieth birthday had odds ratios hovering at or below 1.00 — 0.86 for quitting before age forty, 0.84 for quitting between forty and fifty, and 1.05 for quitting between fifty and sixty. Only those who quit after age sixty retained a non-significant elevation, at an odds ratio of 1.20. Taken together, the duration and age analyses converge on a practical message: stopping smoking at least ten years before old age, or by age sixty at the latest, appears to bring frailty risk down to the level of men who never smoked at all.

Why might the frailty risk of a decades-long smoker rebound so completely after quitting? The leading biological explanation centers on chronic inflammation. Smokers carry persistently elevated levels of C-reactive protein and the pro-inflammatory cytokines interleukin-1 beta and interleukin-6, a phenomenon now often discussed under the banner of inflamm-ageing — the low-grade systemic inflammation that drives cellular senescence, declining physiological reserves, organ dysfunction, and comorbidities such as cardiovascular and respiratory disease, all of which are implicated in frailty’s development. Smoking also directly damages skeletal muscle, eroding the mass and strength that frailty assessment measures. Encouragingly, inflammatory markers have been shown to decline after smoking exposure ceases, which fits neatly with the observation that long-term abstainers in the Singapore cohort looked essentially like never smokers by the time frailty was measured. An additional, simpler mechanism may also be at work: quitting early automatically reduces cumulative lifetime smoking exposure, so early quitters carry a lighter toxicological burden overall.

The study’s design addresses a key weakness of prior work. An analysis of the English Longitudinal Study of Ageing tracked frailty trajectories over sixteen years and found that former smokers with the longest quit durations had the lowest frailty levels, yet never fully closed the gap with never smokers — a discrepancy possibly explained by baseline-only smoking measurement, which would have misclassified relapsers as former smokers and inflated the apparent residual risk. Data from the Survey on Health, Ageing, and Retirement in Europe found elevated frailty worsening in current but not former smokers, without examining timing of cessation. By verifying smoking status at four time points and excluding relapsers, the Singapore team sidestepped both problems. Sensitivity analyses — reclassifying those who quit within two years as persistent smokers, excluding participants with major baseline chronic disease, and applying a stricter three-of-four frailty criterion — produced consistent overall patterns.

Limitations remain, and the authors are candid about them. Frailty was assessed only once, at the third follow-up, so reverse causality cannot be entirely excluded — some former smokers may have become frail before quitting, or long-term abstainers may simply represent a more health-conscious group. The analytic sample was also healthier than the full cohort, being younger, better educated, and less burdened by chronic disease at enrollment, a selection effect that could bias risk estimates toward the null and underestimate the true harms of smoking. And because only men were studied, generalizability to women is uncertain, though a previous Chinese cohort suggested smoking’s association with frailty is stronger in men. Even so, the core conclusion stands as a powerful, biologically plausible piece of evidence that the damage smoking inflicts on the aging body is not a one-way door: quit early enough, and stay quit long enough, and the shadow over one’s final decades may lift almost entirely.

Subject of Research: Smoking cessation duration and timing in relation to late-life physical frailty risk in a prospective cohort of Chinese men in Singapore

Article Title: Association of smoking cessation with late-life frailty risk: the Singapore Chinese health study

Article References: Lee, A. R. Y. B., Li, H., Chua, K. Y., & Koh, W.-P. (2026). Association of smoking cessation with late-life frailty risk: the Singapore Chinese health study. Frontiers in Aging, 7, Article 1870256. https://doi.org/10.3389/fragi.2026.1870256

Image Credits: AI Generated

DOI: 10.3389/fragi.2026.1870256

Keywords: smoking cessation, frailty, aging, Singapore Chinese Health Study, inflammaging, sarcopenia, prospective cohort, healthy longevity, tobacco, physical frailty, handgrip strength, logistic regression